Cor Vasa 2022, 64(Suppl. 4):87-95

The year in cardiovascular medicine 2021: imaging

Chiara Nina Marcelo Edward

¹ Royal Brompton and Harefield Hospitals, Guys' and St Thomas NHS Trust and King's College London, London, UK

² Department of Cardiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands

³ Cardiovascular Imaging Program, Department of Radiology, Heart and Vascular Center, Harvard Medical School, Boston, MA, USA

⁴ Cardiovascular Imaging Program, Department of Medicine, Heart and Vascular Center, Harvard Medical School, Boston, MA, USA

⁵ Division of Cardiovascular Medicine, Department of Medicine, Harvard Medical School, Boston, MA, USA

⁶ Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

Received Date: 16 December 2021; Revision received Date: 02 January 2022; Accepted Date: 01 March 2022
Reproduced from: Bucciarelli-Ducci C, Ajmone-Marsan N, Di Carli M, Nicol E. The year in cardiovascular medicine 2021: imaging. Eur Heart Journal (2022) 43, 1288–1295. https://doi.org/10.1093/eurheartj/ehac033, by permission of Oxford University Press on behalf of the European Society of Cardiology

This article reviews the most relevant literature published in 2021 on the role of cardiovascular imaging in cardiovascular medicine. Coronavirus disease 2019 (COVID-19) continued to impact the healthcare landscape, resulting in reduced access to hospital-based cardiovascular care including reduced routine diagnostic cardiovascular testing. However, imaging has also facilitated the understanding of the presence and extent of myocardial damage caused by the coronavirus infection. What has dominated the imaging literature beyond the pandemic are novel data on valvular heart disease, the increasing use of artifi cial intelligence (AI) applied to imaging, and the use of advanced imaging modalities in both ischaemic heart disease and cardiac amyloidosis.

Keywords: Imaging; Echocardiography; CMR; Magnetic resonance; Cardiac CT; PET; SPECT; Ischaemic heart disease; Valvular heart disease; Amyloidosis

Received: December 21, 2022; Accepted: December 21, 2022; Published: December 30, 2022  Show citation